{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:32:45Z","timestamp":1784302365513,"version":"3.55.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T00:00:00Z","timestamp":1728777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.gore.2024.101531","type":"journal-article","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T14:58:11Z","timestamp":1729004291000},"page":"101531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Ovarian stimulation with letrozole in nulliparous young women with relapsing early-stage serous borderline ovarian tumors"],"prefix":"10.1016","volume":"56","author":[{"given":"Valeria","family":"Lombardi F\u00e4h","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Del Vento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Intidhar Labidi-Galy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Undurraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.gore.2024.101531_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.102031","article-title":"Safety of pregnancy after breast cancer in young women with hormone receptor-positive disease: a systematic review and meta-analysis","volume":"8","author":"Arecco","year":"2023","journal-title":"ESMO Open."},{"issue":"16","key":"10.1016\/j.gore.2024.101531_b0010","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1200\/JCO.2007.14.8700","article-title":"Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study","volume":"26","author":"Azim","year":"2008","journal-title":"J Clin Oncol off J Am Soc Clin Oncol."},{"key":"10.1016\/j.gore.2024.101531_b0015","doi-asserted-by":"crossref","unstructured":"Bonardi B, Massarotti C, Bruzzone M, et al. Efficacy and Safety of Controlled Ovarian Stimulation With or Without Letrozole Co-administration for Fertility Preservation: A Systematic Review and Meta-Analysis. Front Oncol. 2020;10. Accessed December 22, 2023. https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2020.574669.","DOI":"10.3389\/fonc.2020.574669"},{"issue":"5","key":"10.1016\/j.gore.2024.101531_b0020","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s10815-020-01738-1","article-title":"Fertility preservation strategies in borderline ovarian tumor recurrences: different sides of the same coin","volume":"37","author":"Buonomo","year":"2020","journal-title":"J Assist Reprod Genet."},{"issue":"2","key":"10.1016\/j.gore.2024.101531_b0025","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ygyno.2022.02.018","article-title":"Fertility-sparing treatment for serous borderline ovarian tumors with extra-ovarian invasive implants: Analysis from the MITO14 study database","volume":"165","author":"Falcone","year":"2022","journal-title":"Gynecol Oncol."},{"key":"10.1016\/j.gore.2024.101531_b0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bpobgyn.2016.09.012","article-title":"Management of borderline ovarian tumours","volume":"41","author":"Gershenson","year":"2017","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"key":"10.1016\/j.gore.2024.101531_b0035","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejca.2022.07.017","article-title":"Efficacy and safety of controlled ovarian hyperstimulation with or without letrozole for fertility preservation in breast cancer patients: A multicenter retrospective study","volume":"174","author":"Goldrat","year":"2022","journal-title":"Eur J Cancer."},{"issue":"4","key":"10.1016\/j.gore.2024.101531_b0040","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1210\/jc.2015-3878","article-title":"Long-term safety of letrozole and gonadotropin stimulation for fertility preservation in women with breast cancer","volume":"101","author":"Kim","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"10.1016\/j.gore.2024.101531_b0045","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/23809000.2017.1270760","article-title":"Methods of controlled ovarian stimulation for embryo\/oocyte cryopreservation in breast cancer patients","volume":"2","author":"Lambertini","year":"2017","journal-title":"Expert Rev Qual Life Cancer Care."},{"key":"10.1016\/j.gore.2024.101531_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(24)00262-6","article-title":"Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE","author":"Morice","year":"2024","journal-title":"Lancet Oncol."},{"issue":"19","key":"10.1016\/j.gore.2024.101531_b0055","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1200\/JCO.2005.05.037","article-title":"Fertility preservation in breast cancer patients: A prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation","volume":"23","author":"Oktay","year":"2005","journal-title":"J Clin Oncol."},{"issue":"19","key":"10.1016\/j.gore.2024.101531_b0060","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1200\/JCO.2018.78.1914","article-title":"Fertility preservation in patients with cancer: ASCO clinical practice guideline update","volume":"36","author":"Oktay","year":"2018","journal-title":"J Clin Oncol off J Am Soc Clin Oncol."},{"issue":"18","key":"10.1016\/j.gore.2024.101531_b0065","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa2212856","article-title":"Interrupting endocrine therapy to attempt pregnancy after breast cancer","volume":"388","author":"Partridge","year":"2023","journal-title":"N Engl J Med."},{"issue":"2","key":"10.1016\/j.gore.2024.101531_b0070","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ygyno.2020.02.007","article-title":"Fertility-sparing surgery and reproductive-outcomes in patients with borderline ovarian tumors","volume":"157","author":"Plett","year":"2020","journal-title":"Gynecol Oncol."},{"key":"10.1016\/j.gore.2024.101531_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.686625","article-title":"Circulating tumor DNA to interrogate the safety of letrozole-associated controlled ovarian stimulation for fertility preservation in breast cancer patients","volume":"11","author":"Roth\u00e9","year":"2021","journal-title":"Front Oncol."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578924002108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578924002108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:03:35Z","timestamp":1734048215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578924002108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":15,"alternative-id":["S2352578924002108"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2024.101531","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovarian stimulation with letrozole in nulliparous young women with relapsing early-stage serous borderline ovarian tumors","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2024.101531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101531"}}